Literature DB >> 2159892

Desferrioxamine as a lipid chain-breaking antioxidant in sickle erythrocyte membranes.

A Hartley1, M Davies, C Rice-Evans.   

Abstract

The mechanism of action of desferrioxamine in the inhibition of the catalysis of iron-induced oxidative damage has been ascribed to its ability to chelate available ferric ion (Kb = 10(31)). However, recent work has proposed that the trihydroxamate moiety of desferrioxamine can also be involved in electron transfer reactions involving the superoxide radical, peroxidase/hydrogen peroxide mixtures and ferryl myoglobin radicals. In this study we report evidence for the ability of desferrioxamine to inhibit peroxidative damage to pathological membranes with which non-haem iron is associated through a mechanism of action as a lipid chain breaking antioxidant, independently of its iron chelating properties.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2159892     DOI: 10.1016/0014-5793(90)80786-i

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

Review 1.  The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease.

Authors:  K A Jellinger
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

Review 2.  Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice.

Authors:  J Lan; D H Jiang
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

3.  Transdermal deferoxamine prevents pressure-induced diabetic ulcers.

Authors:  Dominik Duscher; Evgenios Neofytou; Victor W Wong; Zeshaan N Maan; Robert C Rennert; Mohammed Inayathullah; Michael Januszyk; Melanie Rodrigues; Andrey V Malkovskiy; Arnetha J Whitmore; Graham G Walmsley; Michael G Galvez; Alexander J Whittam; Michael Brownlee; Jayakumar Rajadas; Geoffrey C Gurtner
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-22       Impact factor: 11.205

Review 4.  Inflammatory responses to ischemia and reperfusion in skeletal muscle.

Authors:  D C Gute; T Ishida; K Yarimizu; R J Korthuis
Journal:  Mol Cell Biochem       Date:  1998-02       Impact factor: 3.396

Review 5.  Towards the prevention of potential aluminum toxic effects and an effective treatment for Alzheimer's disease.

Authors:  Maire E Percy; Theo P A Kruck; Aileen I Pogue; Walter J Lukiw
Journal:  J Inorg Biochem       Date:  2011-08-19       Impact factor: 4.155

6.  Dopamine induces cell death, lipid peroxidation and DNA base damage in a catecholaminergic cell line derived from the central nervous system.

Authors:  J M Masserano; I Baker; D Venable; L Gong; S J Zullo; C R Merril; R J Wyatt
Journal:  Neurotox Res       Date:  2000-02       Impact factor: 3.911

7.  The formation of free radicals by cardiac myocytes under oxidative stress and the effects of electron-donating drugs.

Authors:  J J Turner; C A Rice-Evans; M J Davies; E S Newman
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

8.  Tert-Butyl Hydroperoxide Stimulated Apoptosis Independent of Prostaglandin E2 and IL-6 in the HTR-8/SVneo Human Placental Cell Line.

Authors:  Rita Loch-Caruso; Cassandra S Korte; Kelly A Hogan; Sarah Liao; Craig Harris
Journal:  Reprod Sci       Date:  2020-06-15       Impact factor: 3.060

9.  Impairment of macrophage functions after ingestion of Plasmodium falciparum-infected erythrocytes or isolated malarial pigment.

Authors:  E Schwarzer; F Turrini; D Ulliers; G Giribaldi; H Ginsburg; P Arese
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

10.  Deferoxamine accelerates endothelial progenitor cell senescence and compromises angiogenesis.

Authors:  Yi-Nan Lee; Hsueh-Hsiao Wang; Cheng-Huang Su; Hsin-I Lee; Yen-Hung Chou; Chin-Ling Hsieh; Wen-Ting Liu; Kuo-Tung Shu; Kai-Ting Chang; Hung-I Yeh; Yih-Jer Wu
Journal:  Aging (Albany NY)       Date:  2021-09-11       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.